#molecular diagnostics

[wikipediapictures]

Polymerase chain reaction

“Photo of a strip of PCR tubes, each tube contains a 1000uL (1mL) reaction.” - via Wikimedia Commons

[lostinmirkwood]

I work in molecular diagnostics designing syndromic panel tests for hospital laboratories, it’s pretty cool. We’ve been actively working on Covid-19 tests since we were given government clearance to do so and as part of our parent company we’ve released 2 of the 3 tests in development. This makes us essential employees, I have to be at my desk and in the lab. Salt Lake City went into lockdown Friday and our department is now shuffling who is essential. My boss called me this morning to let me know that since I am actively working on the Covid project and have the skills to cover anyone in our microbiology department should they go down I still have work tomorrow.

It’s nice to be needed but wow that was a weird phone call at 11am on a Sunday while still in my PJs, sipping a cup of tea while in bed relaxing

[renubresearch]

China Molecular Diagnostic Market Forecast

China Molecular Diagnostics Market is projected to reach US$ 1.8 Billion by the end of year 2024. Molecular diagnostics is a technique which is used for the molecular biological detection of any change in the structure or expression of patient’s genetic material. Renub Research report titled “China Molecular Diagnostics Market, Volume, by Application [Oncology Testing (Breast Cancer, Colorectal Cancer, Prostate Cancer), Infectious Disease Testing (Virology, HPV), and Genetic Disease Testing (Blood Screening, HLA)]” provides a complete analysis of China Molecular Diagnostics Market. 

Access full Research:  

https://www.renub.com/china-molecular-diagnostics-market-test-volume-and-forecast-491-p.php

[wikipediapictures]

ELISA

“‘Anti human IgG’ Double Antibody Sandwich ELISA” - via Wikimedia Commons

[wikipediapictures]

RT-PCR Lab EMC

“Biocabinet of the RT-PCR lab setup in Government Medical College Ernakulam for testing Covid 19 infection.” - via Wikimedia Commons

[wikipediapictures]

ELISA

“An ELISA (enzyme-linked immunosorbent assay) on a half-volume 96-well plate developed with a horseradish peroxidase secondary antibody and the colorimetric substrate TMB (3, 3', 5, 5'-tetramethylbenzidine) which reacts with the HRP to turn blue.” - via Wikimedia Commons

[lostinmirkwood]

If anyone was curious as to what I’ve been working on, we submitted to and were cleared by the FDA last week. It’s been a wild ride!

BIOFIRE® Respiratory Panel 2.1 (RP2.1) with SARS-CoV-2 obtains FDA Emergency Use Authorization

BIOFIRE® Respiratory Panel 2.1 (RP2.1) with SARS-CoV-2 obtains FDA Emergency Use Authorization

[gorobagaikwad]

Biotechnology Research Advancing the Future of the Enzymes Market

The Enzymes Market is advancing rapidly due to increasing biotechnology research activities and rising demand for genomic and molecular biology tools worldwide. Enzymes are critical components in numerous scientific and industrial processes, including DNA replication, gene editing, diagnostics, pharmaceutical manufacturing, and synthetic biology applications. The growing focus on precision medicine, biotechnology innovation, and advanced healthcare solutions is driving substantial investments in enzyme development and production technologies. Research institutions, pharmaceutical companies, and biotechnology firms are increasingly utilizing advanced enzymes to improve therapeutic discovery, genetic analysis, and disease diagnostics.

Molecular biology technologies have become essential for modern healthcare and scientific research. DNA modifying enzymes such as nucleases, polymerases, ligases, and methylases are widely used in sequencing, PCR testing, recombinant DNA technology, and gene editing applications. CRISPR-based systems are particularly transforming biotechnology by enabling accurate genetic modifications for medical, agricultural, and industrial purposes. Personalized medicine initiatives are also increasing demand for genomic research tools capable of supporting patient-specific diagnostic and therapeutic approaches. These developments are creating strong growth opportunities for enzyme manufacturers involved in life sciences and biotechnology industries.

The pharmaceutical and healthcare sectors continue investing heavily in biologics production, vaccine development, and molecular diagnostics. Enzyme-based technologies are helping accelerate drug discovery processes and improve manufacturing efficiency for advanced therapies. In addition, synthetic biology innovations are enabling the development of customized enzymes for industrial bioprocessing, renewable chemicals, and sustainable manufacturing applications. Governments and healthcare organizations worldwide are supporting biotechnology research through funding programs, infrastructure investments, and regulatory initiatives aimed at strengthening scientific innovation capabilities. These factors are expected to continue supporting long-term growth within the global enzymes market.

According to recent reports covering the DNA ligase market, the industry is projected to experience strong growth during the forecast period. The Enzymes Market was valued at USD 16.87 Billion in 2025 and is expected to reach USD 38.32 Billion by 2033, growing at a CAGR of 10.80% from 2027 to 2033. Rising investments in biotechnology research, expanding genomic medicine programs, and increasing adoption of molecular diagnostics are expected to drive substantial market expansion globally. Asia-Pacific is emerging as a significant growth region due to expanding pharmaceutical industries, increasing research activities, and supportive government healthcare initiatives.

Leading market players are focusing on innovation, advanced manufacturing technologies, and strategic partnerships to strengthen their competitive position. Artificial intelligence and machine learning technologies are being used to accelerate enzyme discovery, improve protein engineering, and optimize production efficiency. Companies are also investing in high-throughput screening systems and sustainable biotechnology manufacturing processes. As healthcare and biotechnology industries continue evolving rapidly, enzymes will remain central to future scientific advancements, personalized medicine development, and industrial biotechnology innovation worldwide.